Trulieve Cannabis Corp. (TRLV)
Data as of , from SEC Form 4 filings.
See up to 3 months of TRLV. The 7-day demo opens the 1M and 3M ranges and puts TRLV on your watchlist.
Start 7-day demoLatest TRLV insider trades
About Trulieve Cannabis Corp. (TRLV)
Trulieve Cannabis Corp. is an SEC registrant, filing under CIK 0001754195, classified as medicinal chemicals and botanical products. It is grouped with Health Care companies on this site.
TRLV Form 4 activity by transaction type, last 90 days
No Form 4 activity for TRLV in the last 90 days.
TRLV insider transactions (Form 4)
4660 Form 4 filings on record, the earliest from Nov 13, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kim A. Rivers - Officer | Open-market sale | Subordinate Voting Shares | 136,811 | $8.76 footnote F2 | $1.20M | |
| ||||||
| Kim A. Rivers - Officer | Open-market sale | Subordinate Voting Shares | 380,000 | $8.47 footnote F2 | $3.22M | |
| Kim A. Rivers - Officer | Open-market sale | Subordinate Voting Shares | 400,000 | $8.17 footnote F3 | $3.27M | |
| Kim A. Rivers - Officer | Open-market sale | Subordinate Voting Shares | 300,000 | $8.17 footnote F4 | $2.45M | |
| ||||||
| Kim A. Rivers - Officer | Open-market sale | Subordinate Voting Shares | 137,535 | $9.36 footnote F2 | $1.29M | |
| Kim A. Rivers - Officer | Open-market sale | Subordinate Voting Shares | 139,846 | $9.46 footnote F3 | $1.32M | |
| Kim A. Rivers - Officer | Open-market sale | Subordinate Voting Shares | 204,815 | $9.35 footnote F4 | $1.92M | |
| ||||||
| Kim A. Rivers - Officer | Other | Subordinate Voting Shares | 820,000 footnote F1 | $0.00 | - | |
| Kim A. Rivers - Officer | Grant or award | Subordinate Voting Shares | 218,750 footnote F2 | $0.00 | - | |
| Kim A. Rivers - Officer | Other | Multiple Voting Shares | 8,200 footnote F1 | $0.00 | - | |
| Kim A. Rivers - Officer | Grant or award | Stock Option (Right to Buy) | 155,561 | $0.00 | - | |
| ||||||
| Jason Pernell - Officer | Grant or award | Subordinate Voting Shares | 58,594 footnote F1 | $0.00 | - | |
| Jason Pernell - Officer | Grant or award | Stock Option (Right to Buy) | 41,668 | $0.00 | - | |
| ||||||
| Christine Ann Hersey - Officer | Grant or award | Subordinate Voting Shares | 58,594 footnote F1 | $0.00 | - | |
| Christine Ann Hersey - Officer | Grant or award | Stock Option (Right to Buy) | 41,668 | $0.00 | - | |
| ||||||
| Kyle Landrum - Officer | Grant or award | Subordinate Voting Shares | 58,594 footnote F1 | $0.00 | - | |
| Kyle Landrum - Officer | Grant or award | Stock Option (Right to Buy) | 41,668 | $0.00 | - | |
| ||||||
| Jan Reese - Officer | Grant or award | Subordinate Voting Shares | 58,594 footnote F1 | $0.00 | - | |
| Jan Reese - Officer | Grant or award | Stock Option (Right to Buy) | 41,668 | $0.00 | - | |
| ||||||
| Eric Powers - Officer | Grant or award | Subordinate Voting Shares | 58,594 footnote F1 | $0.00 | - | |
| Eric Powers - Officer | Grant or award | Stock Option (Right to Buy) | 41,668 | $0.00 | - | |
| ||||||
| Nilyum Jhala - Officer | Grant or award | Subordinate Voting Shares | 58,594 footnote F1 | $0.00 | - | |
| Nilyum Jhala - Officer | Grant or award | Stock Option (Right to Buy) | 41,668 | $0.00 | - | |
| ||||||
| Brett R. Walsh - Officer | Grant or award | Subordinate Voting Shares | 28,711 footnote F1 | $0.00 | - | |
| ||||||
| Susan Thronson - Director | Grant or award | Subordinate Voting Shares | 23,438 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Subordinate Voting Shares | 23,438 footnote F1 | $0.00 | - | ||
| ||||||
| Matthew J. Foulston - Director | Grant or award | Subordinate Voting Shares | 23,438 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Subordinate Voting Shares | 23,438 footnote F1 | $0.00 | - | ||
| ||||||
| Richard S. May - Director | Grant or award | Subordinate Voting Shares | 23,438 footnote F1 | $0.00 | - | |
| ||||||
| Peter Healy - Director | Grant or award | Subordinate Voting Shares | 23,438 footnote F1 | $0.00 | - | |
| ||||||
| Thad Beshears - Director | Grant or award | Subordinate Voting Shares | 23,438 footnote F1 | $0.00 | - | |
| ||||||
| Matthew J. Foulston - Director | Grant or award | Subordinate Voting Shares | 11,329 footnote F1 | $0.00 | - | |
| Matthew J. Foulston - Director | Grant or award | Stock Option (Right to Buy) | 18,859 | $0.00 | - | |
| ||||||
| Susan Thronson - Director | Grant or award | Subordinate Voting Shares | 18,610 | $0.00 | - | |
| Susan Thronson - Director | Open-market purchase | Subordinate Voting Shares | 3,968 | $6.30 | $25K | |
| Peter Healy - Director | Grant or award | Subordinate Voting Shares | 18,610 | $0.00 | - | |
| Richard S. May - Director | Open-market purchase | Subordinate Voting Shares | 1,610 | $6.05 | $10K | |
| Richard S. May - Director | Grant or award | Subordinate Voting Shares | 18,610 | $0.00 | - | |
| Thad Beshears - Director | Grant or award | Subordinate Voting Shares | 18,610 | $0.00 | - | |
| Kim A. Rivers - Officer | Grant or award | Subordinate Voting Shares | 285,360 | $0.00 | - | |
| Jason Pernell - Officer | Grant or award | Subordinate Voting Shares | 93,052 | $0.00 | - | |
| Eric Powers - Officer | Grant or award | Subordinate Voting Shares | 93,052 | $0.00 | - | |
| Ryan Blust - Officer | Grant or award | Subordinate Voting Shares | 46,922 | $0.00 | - | |
| Joy Malivuk - Officer | Grant or award | Subordinate Voting Shares | 43,424 | $0.00 | - | |
| Kyle Landrum - Officer | Grant or award | Subordinate Voting Shares | 93,052 | $0.00 | - | |
| Timothy Morey - Officer | Grant or award | Subordinate Voting Shares | 86,849 | $0.00 | - | |
Recent TRLV Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
TRLV insider trading FAQ
What is the latest insider trade for TRLV?
Trulieve Cannabis Corp. (TRLV) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-26. The full record for TRLV runs to 60 Form 4 filings, the earliest from 2024-11-13. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TRLV stock?
No insider purchases of TRLV were filed in the last 90 days. 18 purchases are on record for this company.
How many insiders are selling TRLV stock?
No insider sales of TRLV were filed in the last 90 days. 7 sales are on record for this company.
Where can I see TRLV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TRLV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kim A. Rivers view on EDGAR
- - Kim A. Rivers view on EDGAR
- - Kim A. Rivers view on EDGAR
- - Kim A. Rivers view on EDGAR
- - Jason Pernell view on EDGAR
- - Christine Ann Hersey view on EDGAR
- - Kyle Landrum view on EDGAR
- - Jan Reese view on EDGAR
- - Eric Powers view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TRLV's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TRLV with a 7-day demo
- TRLV on your watchlist
- Every TRLV Form 4 filing on record
- Up to 3 months of TRLV price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive